USPTO trademark

CYLLENE THERAPEUTICS

Opposition periodUSPTOWord and designClass 5Class 42

"CYLLENE THERAPEUTICS" is a word and design mark owned by Cyllene Therapeutics, filed at the USPTO on March 3, 2026. It is in its opposition period and covers classes 5 and 42.

Get this data via the API
Official USPTO record
CYLLENE THERAPEUTICS trademark as filed
As filed with the USPTO
Status
Opposition period
Since November 3, 2026
Filed
March 3, 2026
Registered
Not yet
Priority date
September 16, 2025
Claimed from France
Application no.
99679496
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
2 classes
Ownership

Who owns CYLLENE THERAPEUTICS

The owner and representative on file with the office.

Owner

Cyllene Therapeutics

Paris, France

Representative

Pina Campagna

Carter, Deluca, & Farrell, LLP

Goods and services

What the mark covers

The products and services CYLLENE THERAPEUTICS is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Pharmaceutical preparations containing viral vectors for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Medicinal preparations for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for use as treatments of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Chemical reagents for medical or veterinary use; Biological reagents for medical use; Biological reagents for veterinary use; Bacterial preparations for medical purposes; Bacteriological preparations for medical purposes; Biological preparations for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Reagents for medical use; Reagents for veterinary use

  • Research laboratory analysis services in the field of biological, biomedical, and pharmaceutical therapeutics; Research and development services in the field of pharmaceutical preparations; Research and development services in the field of medical preparations; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Pharmaceutical research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Biological research; Scientific research; Medical research; Scientific laboratory services; Scientific research in the field of genetics; Providing medical and scientific research information in the fields of pharmaceuticals and genetics

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Automatic update of assignment of ownership
  5. Approved for pub - principal register
  6. Notification of examiners amendment e-mailed
  7. Examiner's amendment entered
  8. Examiners amendment e-mailed
  9. Examiners amendment -written
  10. Notification of non-final action e-mailed

7 earlier steps on the official record.

FAQ

About CYLLENE THERAPEUTICS

Who owns the trademark "CYLLENE THERAPEUTICS"?

The USPTO trademark "CYLLENE THERAPEUTICS" (application 99679496) is owned by Cyllene Therapeutics.

What is the status of "CYLLENE THERAPEUTICS"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CYLLENE THERAPEUTICS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bb2-4c3d-729a-bb09-1e9d112be5bd
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bb2-4c3d-729a-bb09-1e9d112be5bd",
  "object": "trademark",
  "mark_text": "CYLLENE THERAPEUTICS",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99679496",
  "filing_date": "2026-03-03",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "CYLLENE THERAPEUTICS",
      "entity_id": null
    }
  ]
}